| Serial Number | 99461075 |
| Word Mark | NOVA-BCL6-1 |
| Filing Date | Friday, October 24, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, April 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 28, 2026 |
| Pseudo Mark | NOVA BCL SIX ONE; NOVA-B-CELL LYMPHOMA 6-1; NOVA B-CELL LYMPHOMA 6 1; NOVA-B-CELLLYMPHOMA SIX-ONE; NOVA B-CELL LYMPHOMA SIX ONE |
| Goods and Services | Medical and scientific research in the field of blood diseases and disorders and cancer |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 24, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 US |
| Event Date | Event Description |
| Friday, October 24, 2025 | NEW APPLICATION ENTERED |
| Friday, October 24, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 6, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 11, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, April 1, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 22, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |